SCEMBLIX – Home – MOP Product
Image
SCEMBLIX®▼ (asciminib) hero image.
Image
SCEMBLIX®▼ (asciminib) hero image.

More information

Summary of Product Characteristics (SmPC) for asciminib United Kingdom.

This link will take you to the electronic medicines compendium (emc) website, which is a non-Novartis website.

Patient Information Leaflet (PIL) for asciminib United Kingdom.

This link will take you to the electronic medicines compendium (emc) website, which is a non-Novartis website.


UK | January 2025 | FA-11322763

Reporting side-effects

If you get side-effects with any medication you are taking, talk to your doctor, pharmacist or nurse. This includes any possible side-effects not listed in the information leaflet that comes in the pack. ▼ The medicine referred to in this material is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side-effects you may get. Please see www.mhra.gov.uk/yellowcard. for instructions on how to report side-effects.

Reporting side-effects

If you get side-effects with any medication you are taking, talk to your doctor, pharmacist or nurse. This includes any possible side-effects not listed in the information leaflet that comes in the pack. You can report side-effects via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard.
By reporting side-effects you can help provide more information on the safety of your medication.


Source URL: https://www.pro.novartis.com/uk-en/public/medicines/haematology/scemblix